1. Executive summary
A report published 2026-09-13 states that six in ten cyberattacks recorded in Colombia target health sector institutions, citing a Biofile report based on a measurement analysed from IBM's X-Force Index. The item is a sector-targeting statistic only: it names no victim organisations, no threat actor, no malware family, no exploited vulnerability and no indicators of compromise. No CVE, CVSS score, severity rating or CISA KEV exploitation state is available for this item, and Adverse Trace has resolved no verified reference data against it — no severity assessment is therefore possible and none is offered. For EMEA financial services clients the direct technical risk is nil; the relevance is contextual, namely that healthcare data continues to attract disproportionate targeting in at least one Latin American market, which matters only where a client has Colombian or LatAm health-sector operations, portfolio exposure or third-party dependencies. The underlying figure is single-sourced and unverified — the primary Biofile report and the IBM X-Force Index measurement behind it were not available to us, so the 60% claim should be treated as a media-reported statistic, not as an independently corroborated measurement.
2. Regulatory framing
No specific DORA/NIS2 article is directly engaged by this item.
This is a third-party media report of a regional sector-targeting statistic. It describes no incident at, or affecting, any EMEA financial entity; it identifies no ICT third-party provider in a client's supply chain; and it triggers no incident-management, classification, reporting or testing obligation. Mapping DORA Art. 17–19 or NIS2 Art. 23 to a news statistic about Colombian hospitals would be compliance-checkbox padding, not analysis. The only conditional engagement is geographic and client-specific: if a client has Colombian or LatAm health-sector operations or a material ICT dependency on an entity in that sector, DORA Art. 28 (ICT third-party risk — general principles) and Art. 29 (preliminary assessment of ICT concentration risk) may become relevant to that specific exposure — but that is a function of the client's own footprint, not of anything in this item.
3. Technical analysis & attack chain
There is no attack chain to reconstruct. The source contains no technical detail of any kind, and Adverse Trace will not manufacture one.
What the source actually states. Six in ten cyberattacks recorded in Colombia target health sector institutions — hospitals and clinics. The figure is attributed to a Biofile report, which is itself described as based on "a measurement analyzed from IBM's X-Force Index." The reporting is by Joseph Freixes, published via DataBreaches.net on 2026-09-13. The stated conclusion is that medical information has become one of the main targets.
Provenance chain (as reported): IBM X-Force Index → measurement analysed → Biofile report → DataBreaches.net article. Adverse Trace has not obtained the Biofile report or the underlying X-Force measurement, and cannot verify any link in that chain.
What is absent — and why it matters. The item provides no:
- Time window — the period over which the 60% figure was measured is not stated, so the statistic cannot be trended or compared against prior periods.
- Denominator or methodology — "cyberattacks recorded in Colombia" is undefined: it is unclear whether this counts incident reports, telemetry detections, extortion events or disclosed breaches, and by whom they were "recorded." A 60% share derived from incident-response casework is a materially different claim from one derived from endpoint telemetry.
- Attack-type breakdown — no split between ransomware, data theft and extortion, business email compromise, credential abuse, DDoS or supply-chain compromise. The item does not state that any of these attacks involved ransomware, and Adverse Trace does not characterise them as such.
- Initial access vector, exploited component or CVE — none named.
- Malware capabilities, persistence, privilege escalation, C2, lateral movement or exfiltration detail — none named.
- Named victims, sector sub-segments, or affected systems — none named.
- Threat actor or attribution — none offered. No actor is named, so no MITRE ATT&CK profile mapping is possible and no attribution is asserted here.
Confidence caveat. The entire item rests on a single secondary source (DataBreaches.net) relaying a single primary report (Biofile) that Adverse Trace has not seen. The 60% figure is single-sourced and unverified; treat it as a directional media claim, not an intelligence assessment. Any client decision that depends on the magnitude of the figure should wait for the primary report or an independent measurement.
4. Mitigation & containment
No technical containment or remediation applies: there is no exploited component, no vulnerable version, no vendor fix and no indicator to block. The actions below are the process and exposure controls this story actually implicates, and they are conditional on client footprint.
P1 — within 24 hours
- Determine whether your organisation has Colombian or LatAm health-sector exposure: owned operations, portfolio holdings, insurance or claims exposure, or a material ICT dependency on an entity in that sector. If the answer is no, no further action is required from this advisory.
- If exposure exists, confirm that the relevant entity's incident-reporting path into your group is live and that you would be notified of a material incident — this is a contact-verification exercise, not a technical one.
P2 — within 72 hours
- Where a third-party dependency in that sector exists, confirm the contractual security and incident-notification provisions are current and that you hold an up-to-date assessment of concentration risk for that dependency.
- Review whether your threat model treats healthcare-adjacent data as a high-value target class, and whether any shared service or data flow touches health records.
P3 — within 7 days
- Track down the primary Biofile report and the IBM X-Force Index measurement to establish the time window, methodology and attack-type breakdown. Until then, do not cite the 60% figure in internal risk reporting as a measured value.
- Re-run this assessment if the primary report names specific attack types, actors or vectors; at that point a technical advisory with detection content becomes possible.
5. Indicators of compromise
No indicators of compromise available in the source material.
The source contains no hashes, domains, IP addresses, URLs, file paths, registry keys, mutexes, scheduled-task names or command-line artefacts. No behavioural indicators are described either — the item reports a sector-level statistic with no observable activity attached. There is therefore no atomic indicator table and no copyable block.
6. Detection
Insufficient indicators to author detection rules.
The source provides no distinctive strings, command-line flags, mutex names, scheduled-task or service names, file names or paths, registry keys, ransom-note text or hard-coded values. The only strings present — "Biofile", "IBM X-Force Index", "Colombia", "hospitals" — are reporting metadata and vendor/product names, not artefacts of a threat. A rule built on them would detect reporting about the statistic, not malicious activity, and is deliberately not emitted.
7. Sources
- Joseph Freixes, via DataBreaches.net — "Six in 10 Cyberattacks in Colombia Target Hospitals" — https://databreaches.net/2026/09/13/six-in-10-cyberattacks-in-colombia-target-hospitals/ — published 2026-09-13.
- Biofile report — referenced by the above; not obtained by Adverse Trace. No URL available.
- IBM X-Force Index — referenced by the above as the origin of the underlying measurement; not obtained by Adverse Trace. No URL available.
8. Adverse Trace position
Adverse Trace assesses this item as informational, with no severity rating applicable — no CVE, CVSS score, severity or CISA KEV state exists for it, and we will not assign one. Client impact for EMEA financial services is negligible unless the client has Colombian or LatAm health-sector operations, holdings or ICT dependencies, in which case the item is a prompt to verify notification paths and third-party provisions rather than to take technical action. The single material weakness in this item is evidentiary: the 60% figure is single-sourced, relayed through one secondary outlet from a primary report we have not seen, with no stated time window, methodology or attack-type breakdown — verify before citing it in risk reporting or enforcement decisions. We will attempt to obtain the Biofile report and the underlying IBM X-Force Index measurement; if either names specific attack types, vectors or actors, we will issue a follow-up advisory with technical and detection content. No further action is warranted on the current material.
Published via PulseTrace — Adverse Trace threat intelligence.